Abstract
This is the second in a series of papers that report experiments to investigate the properties required for effective tissue valve implants. This paper is concerned with investigations into alternative antimicrobial treatments and the effect these treatments produce on the structural and biomechanical properties of ovine aortic valves. Six treatments were studied: heat, peracetic acid (at two concentrations), chlorine dioxide, a surfactant cleaning agent and a solvent/detergent treatment. Samples of myocardial tissue were exposed to a mixed bacterial culture or one of three virus cultures and then decontaminated. Two of the six treatments (0.35% peracetic acid and heat) were effective in removing both bacterial and viral contamination, reducing levels of contamination by 2.5 to 3 logs, whilst a third (chlorine dioxide) was effective against viruses (∼ 3 log reduction). Valves subjected to these treatments were examined by microscopy and measurements of mechanical properties were made. All three treatments seriously damaged endothelial cells and leaflet fibroblasts. Heat treatment also damaged connective tissue components (collagen and elastin) but these changes were not seen after chemical treatment .Mechanical testing confirmed severe damage following heat treatment but chemical treatment showed only minor effects on the elasticity of the leaflets and none on extensibility. These minor effects could be mitigated by exposure to a lower dose of peracetic acid and this treatment could be safely combined with cryopreservation or storage in 85% glycerol. Peracetic acid was the preferred disinfection method for use in the subsequent in vivostudies in sheep.
Similar content being viewed by others
References
Aidulis D., Pegg D.E., Hunt C.J., Goffin Y.A.,Vanderkelen A., van Hoeck B. et al. 2002. Processing of ovine cardiac valve allografts: 1. Effects of preservation method on structure and mechanical properties. Cell and Tissue Banking (submitted).
Abd-Elfattah A.S., Messier R.H., Domkowski P.W., Jones J.L., Aly H.M., Crescenzo D.G. et al. 1993. Inhibition of adenosine deaminase and nucleoside transport: Utility in a model of homograft cardiac valve implantation processing. J. Thorac. Cardiovas. Surg. 105: 1095–1105.
Barret-Boyes B.G., Roche A.H.G. and Whitlock R.M.L. 1977. Six year review of the results of free-hand aortic valve replacement using an antibiotic sterilised homograft valve. Circulation 55: 353–361.
Block S.S. 1991. Peroxygen compounds. In: Block S.S. (ed.), Disinfection, Sterilisation and Preservation. 4th edn. Lea and Febiger, London 167–181.
Bodnar E., Parker R., Davies J., Robles J. and Ross D.N. 1990. Non-viable aortic homografts. In: Bodnar E. (ed.), Surgery for Heart Valve Disease. ICR, London, pp. 494–500.
Brockbank K.G.M., Carpenter J.F. and Dawson P.E. 1992. Effects of storage temperature on viable bioprosthetic heart valves. Cryobiology 29: 537–542.
Coates D. 1996. Sporicidal activity of sodium dichloroisocyanourate, peroxygen and glutaraldehyde disinfectants against Bacillus subtilis. J. Hosp. Infect. 32: 283–294.
Dychdala G.R. 1991. Chlorine and chlorine compounds. In: Block S.S. (ed.), Disinfection, Sterilisation and Preservation. 4th edn. Lea and Febiger, London 131–151.
Eastlund T. 1995. Infectious disease transmission through cell, tissue and organ transplantation: reducing the risk through donor selection. Cell. Transplant. 4: 455–477.
Fischlein T., Schutz A., Haushofer M., Frey R., Uhlig A., Detter C. et al. 1995. Immunologic reaction and viability of cryopreserved homografts. Ann. Thorac. Surg. 60: S122–S126.
Gavin J.B., Herdson P.B. and Barret-Boyes B.G. 1972. The pathology of chemically sterilized heart valve allografts. Pathol. 4: 175–183.
Goffin Y.A.H., Gouveia H.R., Szombathelyi T., Troussaint M.J.M. and Gruys E. 1997. Morphologic study of homograft valves before and after cryopreservation and after short-term implantation in patients. Cardiovasc. Pathol. 6: 35–42.
Horowitz B., Bonomo R., Prince A.M., Chin S.N., Brotman B. and Shulman R.W. 1992. Solvent / detergent-treated plasma: A virusinactivated substitute for fresh frozen plasma. Blood 79: 826–831.
Hu J.-F., Gilmer L., Hopkins R. and Wolfinbarger L. 1989. Effects of antibiotics on cellular viability in porcine heart valve tissue. Cardiovas Res. 23: 960–964.
Keuhnert M.J., Clarke E., Lockhart S.R., Soll D.R., Chia J. and Jarvis W.R. 1998. Candida albicans endocarditis associated with a contaminated aortic valve allograft: Implications for regulation of allograft processing. Clin. Inf. Dis. 27: 688–691.
Kline L.B. and Hull R.N. 1960. The virucidal properties of peracetic acid. Am. J. Clin. Pathol. 33: 30–33.
Koneman E.W. and Davis M.A. 1974. Postmortem bacteriology III. Clinical significance of microorganisms recovered at autopsy. Am. J. Clin. Pathol. 61: 28–40.
Lang S.J., Giordano M.S., Cardon-Cardo C., Summers B.D., Staiano-Coico L. and Hajjar D.P. 1994. Biochemical and cellular characterization of cardiac valve tissue after cryopreservation or antibiotic preservation. J. Thorac. Cardiovasc. Surg. 108: 63–67.
Leaper S. 1984. Synergistic killing of spores of Bacillus subtilis by peracetic acid and alcohol. J. Food Technol. 19: 355–360.
Lupinetti F.M., Tsai T.T., Kneebone J.M. and Bove E.L. 1993. Effect of cryopreservation on the presence of endothelial cells on human valve allografts. J. Thorac. Cardiovasc. Surg 106: 912–917.
Lynam P.A., Babb J.R. and Fraise A.P. 1995. Comparison of the mycobacterial activity of 2% alkaline glutaraldhyde and Nu-Cidex (0.35% peracetic acid). J. Hosp. Infect. 30: 237–240.
Martinez O.V., Malinin T.I., Valla P.H. and Flores A. 1985. Postmortem bacteriology of cadaver tissue donors: An evaluation of blood cultures as an index of tissue sterility. Diag Microbiol. Infect. Dis. 3: 193–200.
Missen G.A. and Roberts C.I. 1970. Calcification and cusp rupture in human aortic valve homografts sterilised by ethylene oxide and freeze dried. Lancet 2: 962–964.
Mitchell R.N., Jonas R.A. and Schoen F.J. 1995. Structure-function correlations in cryopreserved allograft cardiac valves. Ann. Thorac. Surg. 60: 108–113.
Nagington J., Sutehall G.M. and Whipp P. 1983. Tonometer disinfection and viruses. Br. J. Ophthalmol. 67: 674–676.
Nowak T., Niedrig M., Bernhardt D. and Hilfenhaus J. 1993. Inactivation of HIV, HBV, HCV related viruses and other viruses in human derivatives by pasteurisation. Dev. Biol. Stand 81: 125–135.
O'Brien M.F., Stafford E.G., Gardener M.A.H., Pohlner P.F., Tesar P.J., Cochrane A.D. et al. 1995. Allograft aortic valve replacement: Long-term follow-up. Ann. Thorac. Surg. 60: S65–S70.
Piet M.P.J., Chin S., Prince A.M., Brotman B., Cundell A.M. and Horowitz B. 1990. The use of tri(n-butyl)phosphate detergent mixtures to inactivate hepatitis viruses and human immuno-deficiency virus in plasma and plasma's subsequent fractionation. Transfusion 30: 591–598.
Pruss A., Kao M., Kiesewetter H., vonVersen R. and Pauli G. 1999. Virus safety of avital bone tissue transplants: evaluation of sterilisation steps of spongiousa cuboids using a peracetic acid-methanol mixture. Biologicals 27: 195–201.
Strickett M.G., Barret-Boyes B.G. and MacCullouch D. 1983. Disinfection of human heart valve allografts with antibiotics in low concentration. Pathol 15: 457–462.
Wain W.H., Pearce H.M., Riddell R.W. and Ross D.N. 1977. A re-evaluation of antibiotic sterilisation of heart valve allografts. Thorax 32: 740–742.
Warwick R.M., Eastlund T. and Fehily D. 1996. Role of the blood transfusion service in tissue banking. Vox Sang 71: 71–77.
Waterworth P.M., Lockey E., Berry E.M. and Pearce H.M. 1974. A critical investigation into the antibiotic sterilisation of heart valve homografts. Thorax 29: 432–437.
Yankah A.C., Wottge H.-U., Muller-Hermelink H.K., Feller A.C., Lange P., Wessel U. et al. 1987. Transplantation of aortic and pulmonary allografts, enhanced viability of endothelial cells by cryopreservation, importance of histocompatibility. J. Cardiac. Surg 1 (suppl): 209–220.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Farrington, M., Wreghitt, T., Matthews, I. et al. Processing of cardiac valve allografts: 2. Effects of antimicrobial treatment on sterility, structure and mechanical properties.. Cell Tissue Banking 3, 91–103 (2002). https://doi.org/10.1023/A:1022815013948
Issue Date:
DOI: https://doi.org/10.1023/A:1022815013948